Clinical trial
A single center, randomized, open-label, comparative study to assess efficacy and safety of piracetam 4.8g/d administered for 6 months as adjuvant to standard vestibular rehabilitation (VR) therapy utilizing Cooksey Cawthorne exercises to adults suffering
To ascertain whether adding piracetam to vestibular rehabilitation (VR) contributes to the improvement of abnormal neuro-otological findings including ENG at the end of the 180-day treatment period compared to baseline
| Category | Value |
|---|---|
| Study start date | 2006-12-04 |